An outstanding research paper was published in the top rated Journal of Allergen and Clinical Immunology which evaluated the performance of basophil activation as a biomarker in monitoring clinical efficacy of oral peanut immunotherapy in a clinical trial.
- info@buhlmannlabs.ch
- +41 61 487 12 12
Blog Archives
The benefits of remote monitoring in the care of patients with chronic diseases for the health care system are obvious and gradually on the way to becoming the new standard of care.
BÜHLMANN is proud to add Quantum Blue® Anti-Infliximab (RUO) and Quantum Blue® Anti-Adalimumab (RUO) to the TDM rapid test portfolio.
A French medical TV show presented a story about how healthcare professionals and patients are using IBDoc®, the fecal calprotectin home test, to improve their control over the disease.
Social Links